Skip to content

Pain in Adults With Autism Spectrum Disorder

Pain Neuromodulation in Adults With Autism Spectrum Disorder

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02277756
Acronym
DOUPA
Enrollment
39
Registered
2014-10-29
Start date
2015-05-29
Completion date
2017-04-05
Last updated
2017-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism, Pain

Keywords

high functioning autism, endogenous modulation systems

Brief summary

Pain insensibility is often described in people with autism. The aim of this study is to test the pain perception in adults with autistic spectrum disorder without intellectual disability. An experimental model of pain is used to measure endogenous modulation systems. Thermic stimulations (tonic heat pain stimulation and cold-pressor test) are used to test excitatory and inhibitory pain mechanisms. Salivary cortisol and automatic nervous system (heart rate and blood pressure with an electrocardiogram (Brest :system dantec keypoint natus G3 ; Paris: nexfin HD®) are also tested and behavioral response to thermal stimulation assessed by an inspired behavior scale.

Detailed description

Adults with autism without intellectual disability (IQ \> 85) are matched with members of siblings and control group (sex and chronological age). Pain reactivity (Visual analog scale,endogenous modulation systems, salivary cortisol, automatic nervous system and behavioral responses to thermal stimulation assessed by an inspired behavior scale.) in adult with autism is tested using an experimental model of pain. Excitatory and inhibitory modulation systems were elicited using a temporal summation test administered before and after activation of the Diffuse Noxious Inhibitory Control (DNIC) by means of a cold-pressor test. Demographic and clinical data are also collected (sensory profile, sleep disorders and depression inventory).

Interventions

DEVICEthermode

thermal stimulation with test thermode

Sponsors

University Hospital, Brest
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Non-specific inclusion criteria: * intellectual quotient \>85 * consent form signed Inclusion Criteria autism group : * autism diagnosis (CIM 10) from multidisciplinary evaluation (ADI-r, ADOS) * sibling without autism or developmental disorder Non-specific

Exclusion criteria

* chronic pain * pregnancy, breast feeding * consent form no signed

Design outcomes

Primary

MeasureTime frame
Pain as assessed by Computerized Visual analog scaleone day

Secondary

MeasureTime frame
salivary cortisolone day
Behavioral response to thermal stimulation assessed by an inspired EDM-DI behavior scaleone day
heart rate variabilityone day

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026